Evidence map›Paper›PMID 39136459›Full record

ArticleJournal of virology2024

The Rab6 post-Golgi secretory pathway contributes to herpes simplex virus 1 (HSV-1) egress.

Melissa H Bergeman, Kimberly Velarde, Hailee L Hargis, Honor L Glenn, Ian B Hogue

Abstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Cell death network regulation in HSV infection: immune evasion versus host defense.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Virus infection and vesicle trafficking.Frontiers in immunology · 2025
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Melissa H BergemanASU-Banner Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Kimberly VelardeSchool of Life Sciences, Arizona State University, Tempe, Arizona, USA.
Hailee L HargisASU-Banner Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Honor L GlennCenter for Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Ian B HogueASU-Banner Neurodegenerative Disease Research Center, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-1977-5573

Funding

Molecular and cellular mechanisms of HSV-1 assembly and egressR01NS117513 · NINDS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Ian B Hogue · 2022 to 2026
$2.0M
Molecular and Cellular Mechanisms of Herpes Simplex Transport and Egress Pathway in NeuronsK22AI123159 · NIAID · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HOGUE, IAN B · 2017 to 2018
$261k
NIAID NIH HHS K22 AI123159NINDS NIH HHS R01 NS117513
6 · The paper itself

Abstract

Herpes simplex virus 1 (HSV-1) is an alpha herpesvirus that infects a majority of the world population. The mechanisms and cellular host factors involved in the intracellular transport and exocytosis of HSV-1 particles are not fully understood. To elucidate these late steps in the replication cycle, we developed a live-cell fluorescence microscopy assay of HSV-1 virion intracellular trafficking and exocytosis. This method allows us to track individual virus particles and identify the precise moment and location of particle exocytosis using a pH-sensitive reporter. We show that HSV-1 uses the host cell's post-Golgi secretory pathway during egress. The small GTPase, Rab6, binds to nascent secretory vesicles at the IMPORTANCE: Herpes simplex virus 1 (HSV-1) infects a majority of people. It establishes a life-long latent infection and occasionally reactivates, typically causing characteristic oral or genital lesions. Rarely in healthy natural hosts, but more commonly in zoonotic infections and in elderly, newborn, or immunocompromised patients, HSV-1 can cause severe herpes encephalitis. The precise cellular mechanisms used by HSV-1 remain an important area of research. In particular, the egress pathways that newly assembled virus particles use to exit from infected cells are unclear. In this study, we used fluorescence microscopy to visualize individual virus particles exiting from cells and found that HSV-1 particles use the pre-existing cellular secretory pathway.

Indexed as

ExocytosisGolgi ApparatusHerpesvirus 1, Humanrab GTP-Binding ProteinsSecretory PathwayVirus ReleaseAnimalsCell MembraneChlorocebus aethiopsHeLa CellsHerpes SimplexHumanstrans-Golgi NetworkVero CellsVirionRab6 proteinrab GTP-Binding Proteinsegressexocytosisfluorescent image analysisherpes simplex virusherpesvirusesmembrane transportsecretory pathway

Identifiers

PMID39136459
PMCPMC11406995

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.